| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10738 | 2021 |
| Edoxaban versus warfarin in patients with atrial fibrillation RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ... New England Journal of Medicine 369 (22), 2093-2104, 2013 | 5830 | 2013 |
| The TIMI risk score for unstable angina/non–ST elevation MI: a method for prognostication and therapeutic decision making EM Antman, M Cohen, PJLM Bernink, CH McCabe, T Horacek, ... Jama 284 (7), 835-842, 2000 | 4544 | 2000 |
| Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel … SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ... Circulation 116 (25), 2923-2932, 2007 | 1816* | 2007 |
| Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes PURSUIT Trial Investigators New England Journal of Medicine 339 (7), 436-443, 1998 | 1676 | 1998 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1440 | 2011 |
| Prasugrel versus clopidogrel for acute coronary syndromes without revascularization MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ... New England journal of medicine 367 (14), 1297-1309, 2012 | 1082 | 2012 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 929 | 2018 |
| Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. SR Mehta, S Yusuf, R Díaz, J Zhu, P Pais, D Xavier, E Paolasso, R Ahmed, ... Jama 293 (4), 437-446, 2005 | 886 | 2005 |
| Darapladib for preventing ischemic events in stable coronary heart disease Stability Investigators New England Journal of Medicine 370 (18), 1702-1711, 2014 | 553 | 2014 |
| Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... New England Journal of Medicine 384 (2), 105-116, 2021 | 532 | 2021 |
| Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease MP Bonaca, DL Bhatt, RF Storey, PG Steg, M Cohen, J Kuder, E Goodrich, ... Journal of the American College of Cardiology 67 (23), 2719-2728, 2016 | 408 | 2016 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 400 | 2018 |
| Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis S Goto, DL Bhatt, J Röther, M Alberts, MD Hill, Y Ikeda, S Uchiyama, ... American heart journal 156 (5), 855-863. e2, 2008 | 338 | 2008 |
| Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved … RP Giugliano, CP Cannon, MA Blazing, JC Nicolau, R Corbalán, J Špinar, ... Circulation 137 (15), 1571-1582, 2018 | 335 | 2018 |
| Ticagrelor in patients with stable coronary disease and diabetes PG Steg, DL Bhatt, T Simon, K Fox, SR Mehta, RA Harrington, C Held, ... New England journal of medicine 381 (14), 1309-1320, 2019 | 334 | 2019 |
| Psychologic stress and threshold for repetitive ventricular response B Lown, R Verrier, R Corbalan Science 182 (4114), 834-836, 1973 | 322 | 1973 |
| Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release R Corbalan, RL Verrier, B Lown American Heart Journal 92 (2), 223-230, 1976 | 226 | 1976 |
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial JA Udell, DL Bhatt, E Braunwald, MA Cavender, O Mosenzon, PG Steg, ... Diabetes care 38 (4), 696-705, 2015 | 216 | 2015 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 202 | 2019 |
